Maricann Group, Inc. Gains Exposure to TSX with Listing on Horizons Marijuana Life Sciences Index ETF

Facts on How to Grow Cannabis with Artificial Lights
Infinity Supercritical Introduces New Ultra-Efficient Organic Method of Botanical Oil Extraction
June 20, 2017
Facts on How to Grow Cannabis with Artificial Lights
Weed causing painful blisters returns to QCA – KWQC-TV6
June 20, 2017

Maricann Group, Inc. Gains Exposure to TSX with Listing on Horizons Marijuana Life Sciences Index ETF

Facts on How to Grow Cannabis with Artificial Lights

TORONTO, Ontario, June 20, 2017 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (“Maricann” or the “Company”) a low cost, greenhouse producer of medical cannabis with market leading technological differentiation, is proud to announce that it has been added to the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ). The company was selected to join the cannabis industry’s premier ETF due to its continued strong performance in the competitive Canadian cannabis landscape, as well as having proven to meet the Index’s required asset and liquidity thresholds.

“Maricann Group is a growth-oriented company in an expanding and exciting sector,” said Ben Ward, CEO of Maricann. “We’re pleased to be included in the Horizon Marijuana Life Sciences Index ETF (HMMJ), giving us increased exposure to investors through the ETF’s TSX listing.”

Debuting on the Toronto Stock Exchange on April 5th, 2017, HMMJ is the first exchange-traded fund that will offer investors direct exposure to North American-listed stocks that are involved with biopharmaceuticals, medical manufacturing, distribution, bio-products, and other businesses ancillary to the marijuana industry. Maricann joins the group of 20 stocks tracked by the HMMJ ETF.

“We are confident that our inclusion will prove beneficial to both the Company and ETF alike,” said Ward. “Maricann has a fully funded expansion into Germany underway, with the infrastructure for cultivation of cannabis in an indoor secured environment already in place. Germany is our gateway into all of Europe, and as cannabis legalization continues to sweep through the continent, we will be well poised to grow our European presence.”

This milestone follows Maricann’s announcement of international expansion, after securing $42,500,000 in non-dilutive financing to further expand their operation into Germany. Maricann is slated to produce 40,000 kilograms of cannabis per year across 150,000 square feet inside their new GMP-compliant, clean-room cultivation facility in Dresden. With the potential for 820,000 square feet of clean-room cultivation in this facility, Maricann can increase production and scale capabilities in Europe’s largest market for medical cannabis.

For more information about the HMMJ ETF, including the full list of securities and the index methodology, visit the HMMJ ETF website at www.horizonsetfs.com/ETF/HMMJ.

About Maricann Group Inc.

Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Langton, Ontario, where it operates a medicinal cannabis cultivation, extraction and distribution business under federal licence from the Government Continue Reading


*This page contains viral feeds. We aggregate all of this content. This site shares recent posts, images and links from viral sources. All material is copyright to their respectful sources and no copyright infringement is intended.

Leave a Reply

Are you over 18?

Please verify your age